Analysis shows linear non-ionic gadolinium agents may worsen dentate nucleus hyperintensity in patients, suggesting hormone therapy impacts gadolinium metabolism.
Motivation: Breast cancer patients often require multiple MRIs to track disease progression. Studies have linked contrast injections to dentate nucleus (DN) hyperintensity, with linear non-ionic agents being more harmful. Goal(s): This study aims to evaluate the association between DN hyperintensity on non-enhanced T1WI and prior use of different types of linear GBCAs Approach: This study compared DN hyperintensity on T1WI for two contrast types and identified factors influencing it. Results: We found that linear non-ionic deposition was more severe. Additionally, we discovered for the first time that hormone therapy may cause gadolinium ions to dissociate from the brain. Impact: Our results suggest that hormone therapy in breast cancer patients may lead to re-metabolism of gadolinium ions in the body, potentially increasing the toxicity of gadolinium when combined with other particles. This finding warrants further investigation.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: